NCT03270332View on ClinicalTrials.gov

Effect of Inhaled Albuterol in Pulmonary Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 5, 2017

Primary Completion Date

July 2, 2020

Study Completion Date

July 2, 2020

Conditions
Pulmonary Hypertension
Interventions
DRUG

Albuterol

inhalation of 270μg albuterol through a spacer

DRUG

Placebo

inhalation of placebo through a spacer

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT03270332 - Effect of Inhaled Albuterol in Pulmonary Hypertension | Biotech Hunter | Biotech Hunter